BBIO logo

BridgeBio Pharma (BBIO) Operating profit

annual operating profit:

-$577.37M+$22.08M(+3.68%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual operating income is -$577.37 million, with the most recent change of +$22.08 million (+3.68%) on December 31, 2024.
  • During the last 3 years, BBIO annual operating profit has fallen by -$736.00 thousand (-0.13%).
  • BBIO annual operating profit is now -1216.45% below its all-time high of -$43.86 million, reached on December 31, 2017.

Performance

BBIO Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

quarterly operating profit:

-$103.80M+$117.53M(+53.10%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly operating income is -$103.80 million, with the most recent change of +$117.53 million (+53.10%) on March 31, 2025.
  • Over the past year, BBIO quarterly operating profit has dropped by -$107.55 million (-2873.23%).
  • BBIO quarterly operating profit is now -2873.23% below its all-time high of $3.74 million, reached on March 31, 2024.

Performance

BBIO quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

TTM operating profit:

-$684.91M-$107.55M(-18.63%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO TTM operating income is -$684.91 million, with the most recent change of -$107.55 million (-18.63%) on March 31, 2025.
  • Over the past year, BBIO TTM operating profit has dropped by -$212.01 million (-44.83%).
  • BBIO TTM operating profit is now -1537.06% below its all-time high of -$41.84 million, reached on March 31, 2018.

Performance

BBIO TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

BBIO Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.7%-2873.2%-44.8%
3 y3 years-0.1%+31.3%-22.3%
5 y5 years-116.9%-1.3%-124.6%

BBIO Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.3%+3.7%-2873.2%+53.1%-55.6%at low
5 y5-year-116.9%+3.7%-2873.2%+53.1%-124.6%at low
alltimeall time-1216.5%+3.7%-2873.2%+53.1%-1537.1%at low

BBIO Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$103.80M(-53.1%)
-$684.91M(+18.6%)
Dec 2024
-$577.37M(-3.7%)
-$221.33M(+18.3%)
-$577.37M(+8.4%)
Sep 2024
-
-$187.13M(+8.4%)
-$532.70M(+5.9%)
Jun 2024
-
-$172.65M(-4712.6%)
-$502.99M(+6.4%)
Mar 2024
-
$3.74M(-102.1%)
-$472.91M(-21.1%)
Dec 2023
-$599.44M(+28.0%)
-$176.66M(+12.2%)
-$599.44M(+10.1%)
Sep 2023
-
-$157.42M(+10.4%)
-$544.32M(+6.5%)
Jun 2023
-
-$142.57M(+16.1%)
-$511.00M(+16.1%)
Mar 2023
-
-$122.79M(+1.0%)
-$440.21M(-6.0%)
Dec 2022
-$468.44M(-18.8%)
-$121.54M(-2.1%)
-$468.44M(-8.6%)
Sep 2022
-
-$124.10M(+72.9%)
-$512.51M(-4.7%)
Jun 2022
-
-$71.78M(-52.5%)
-$537.91M(-4.0%)
Mar 2022
-
-$151.02M(-8.8%)
-$560.14M(-2.9%)
Dec 2021
-$576.63M
-$165.61M(+10.8%)
-$576.63M(+7.1%)
Sep 2021
-
-$149.50M(+59.0%)
-$538.51M(+5.8%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$94.02M(-43.9%)
-$508.95M(-5.7%)
Mar 2021
-
-$167.50M(+31.4%)
-$539.50M(+13.7%)
Dec 2020
-$474.48M(+78.2%)
-$127.49M(+6.3%)
-$474.48M(+11.5%)
Sep 2020
-
-$119.94M(-3.7%)
-$425.63M(+18.2%)
Jun 2020
-
-$124.57M(+21.5%)
-$360.22M(+18.1%)
Mar 2020
-
-$102.49M(+30.3%)
-$304.98M(+14.5%)
Dec 2019
-$266.24M(+45.0%)
-$78.64M(+44.2%)
-$266.24M(+5.2%)
Sep 2019
-
-$54.53M(-21.3%)
-$253.19M(+5.4%)
Jun 2019
-
-$69.32M(+8.7%)
-$240.11M(+16.8%)
Mar 2019
-
-$63.75M(-2.8%)
-$205.57M(+11.9%)
Dec 2018
-$183.66M(+318.8%)
-$65.58M(+58.2%)
-$183.66M(+55.5%)
Sep 2018
-
-$41.46M(+19.2%)
-$118.08M(+54.1%)
Jun 2018
-
-$34.78M(-16.9%)
-$76.62M(+83.1%)
Mar 2018
-
-$41.84M
-$41.84M
Dec 2017
-$43.86M
-
-

FAQ

  • What is BridgeBio Pharma annual operating income?
  • What is the all time high annual operating profit for BridgeBio Pharma?
  • What is BridgeBio Pharma annual operating profit year-on-year change?
  • What is BridgeBio Pharma quarterly operating income?
  • What is the all time high quarterly operating profit for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly operating profit year-on-year change?
  • What is BridgeBio Pharma TTM operating income?
  • What is the all time high TTM operating profit for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM operating profit year-on-year change?

What is BridgeBio Pharma annual operating income?

The current annual operating profit of BBIO is -$577.37M

What is the all time high annual operating profit for BridgeBio Pharma?

BridgeBio Pharma all-time high annual operating income is -$43.86M

What is BridgeBio Pharma annual operating profit year-on-year change?

Over the past year, BBIO annual operating income has changed by +$22.08M (+3.68%)

What is BridgeBio Pharma quarterly operating income?

The current quarterly operating profit of BBIO is -$103.80M

What is the all time high quarterly operating profit for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly operating income is $3.74M

What is BridgeBio Pharma quarterly operating profit year-on-year change?

Over the past year, BBIO quarterly operating income has changed by -$107.55M (-2873.23%)

What is BridgeBio Pharma TTM operating income?

The current TTM operating profit of BBIO is -$684.91M

What is the all time high TTM operating profit for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM operating income is -$41.84M

What is BridgeBio Pharma TTM operating profit year-on-year change?

Over the past year, BBIO TTM operating income has changed by -$212.01M (-44.83%)
On this page